Texas 2025 89th Regular

Texas House Bill HB1088 Introduced / Bill

Filed 11/12/2024

Download
.pdf .doc .html
                    89R5234 SCL-F
 By: Slawson H.B. No. 1088




 A BILL TO BE ENTITLED
 AN ACT
 relating to the statute of limitations on a health care liability
 claim involving certain gender modification drugs provided to and
 procedures performed on a minor.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 74.251, Civil Practice and Remedies
 Code, is amended to read as follows:
 Sec. 74.251.  GENERAL STATUTE OF LIMITATIONS AND REPOSE ON
 HEALTH CARE LIABILITY CLAIMS. (a) Notwithstanding any other law,
 except as provided by Section 74.252, and subject to Subsection
 (b), no health care liability claim may be commenced unless the
 action is filed within two years from the occurrence of the breach
 or tort or from the date the medical or health care treatment that
 is the subject of the claim or the hospitalization for which the
 claim is made is completed; provided that, minors under the age of
 12 years shall have until their 14th birthday in which to file, or
 have filed on their behalf, the claim. Except as herein provided
 this section applies to all persons regardless of minority or other
 legal disability.
 (b)  Except for a health care liability claim described by
 Section 74.252, a [A] claimant must bring a health care liability
 claim not later than 10 years after the date of the act or omission
 that gives rise to the claim.  This subsection is intended as a
 statute of repose so that all claims must be brought within 10 years
 or they are time barred.
 SECTION 2.  Subchapter F, Chapter 74, Civil Practice and
 Remedies Code, is amended by adding Section 74.252 to read as
 follows:
 Sec. 74.252.  STATUTE OF LIMITATIONS ON HEALTH CARE
 LIABILITY CLAIMS INVOLVING CERTAIN GENDER MODIFICATION DRUGS AND
 PROCEDURES. A claimant must bring a health care liability claim not
 later than the claimant's 25th birthday if:
 (1)  the claimant is a minor at the time the cause of
 action accrues; and
 (2)  the basis for the claim is malpractice in the
 provision of a puberty suppression prescription drug or cross-sex
 hormone to or the performance of surgery or another medical
 procedure on the minor for the purpose of gender transitioning or
 gender reassignment.
 SECTION 3.  The changes in law made by this Act apply only to
 a cause of action that accrues on or after the effective date of
 this Act.
 SECTION 4.  This Act takes effect September 1, 2025.